News | November 07, 2024
Vijaya Diagnostic Centre posts Q2 FY25 PAT at Rs. 41.95 Cr
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Testing supporting allergy diagnosis now accessible to more people in more communities
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The blood test market worldwide is today around $75-80 billion
A First of its Kind Initiative in Mahbubnagar District for Medical Officers, ANM, Anganwadi workers for prevention of Thalassemia and Sickle Cell anemia as part of Antenatal screening of pregnant women project
Subscribe To Our Newsletter & Stay Updated
